l-Carnitine and the recovery from exhaustive endurance exercise: a randomised, double-blind, placebo-controlled trial
- 471 Downloads
We hypothesised that l-carnitine could accelerate recovery from exhaustive exercise since increased blood l-carnitine concentrations elicit a vasodilation in isolated animal vessels as well as in patients with peripheral vascular or coronary artery disease during exercise. Twelve subjects received either 2 g l-carnitine or a placebo in a study which was double-blind and crossover in design. Two hours after administration, the subjects performed a constant-load exercise test (CET1) cycling at their individual anaerobic threshold to exhaustion. Three hours later this test was repeated (CET2). After 4–14 days, each subject performed the same cycling tests after having taken the other substance. Exercise times of the 12 subjects were identical with l-carnitine (CET1: 21.3±5.7 min; CET2: 21.4±5.3 min) and placebo (CET1: 21.9±6.2 min; CET2: 20.4±4.8 min). Also, heart rate, oxygen consumption, respiratory exchange ratio, and blood lactate concentration were identical. In conclusion, 2 g of L-carnitine taken 2 h before a first of two constant-load exercise tests had no influence on the second tests performed 3 h after the first test compared with placebo.
KeywordsConstant-load exercise Vasodilative effect Endurance performance
We thank Sigma-Tau Switzerland, who kindly supplied identical l-carnitine and placebo tablets, and Wander, who donated Isostar.
- Bettini V, Aragno R, Bettini MB, Braggion G, Calore L, Concolato MT, Favaro P, Montin S (1990) Partecipazione del fattore endoteliale di rilasciamento negli effetti colinomimetici della carnitina in arterie isolate. Med Sport 43:153–160Google Scholar
- Brass EP (2000) Supplemental carnitine and exercise. Am J Clin Nutr 72(Suppl):S618–S623Google Scholar
- Colombani P, Wenk C, Kunz I, Kraehenbuehl S, Kuhnt M, Arnold M, Frey-Rindova P, Frey W, Langhans W (1996) Effects of l-carnitine supplementation on physical performance and energy metabolism of endurance-trained athletes: a double-blind crossover field study. Eur J Appl Physiol 73:434–439CrossRefGoogle Scholar
- Rizza V, Lorefice R, Rizza N, Calabrese V (1992) Pharmacokinetics of l-carnitine in human subjects. In: Ferrari R, Sherwood SDWG (eds) l-Carnitine and its role in medicine: From function to therapy. Academic, London, pp 63–77Google Scholar
- Signorelli SS, Malaponte G, di Pino L, Digrandi D, Pennisi G, Mazzarino MC (2001) Effects of ischaemic stress on leukocyte activation processes in patients with chronic peripheral occlusive arterial disease: role of l-propionyl carnitine administration. Pharmacol Res 44:305–309PubMedCrossRefGoogle Scholar